A carregar...
Bioavailability of a dexlansoprazole delayed-release orally disintegrating tablet: effects of food and mode of administration
BACKGROUND: Dexlansoprazole is a proton pump inhibitor (PPI) approved for use in dual delayed-release capsule and orally disintegrating tablet (ODT) formulations. AIM: To assess effects of food, water, and route of administration on the bioavailability of dexlansoprazole 30-mg ODT. METHODS: Two sepa...
Na minha lista:
| Publicado no: | Clin Exp Gastroenterol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5323062/ https://ncbi.nlm.nih.gov/pubmed/28255251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S121129 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|